<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Epidemiology and Population Health</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/619E3947-5752-4D28-92B2-2AFB9304AAEE"><gtr:id>619E3947-5752-4D28-92B2-2AFB9304AAEE</gtr:id><gtr:firstName>Saidi</gtr:firstName><gtr:surname>Kapiga</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3F774323-0469-4DDF-82AD-CFFC512C6285"><gtr:id>3F774323-0469-4DDF-82AD-CFFC512C6285</gtr:id><gtr:firstName>Richard John</gtr:firstName><gtr:surname>Hayes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/47B97F2C-E1E7-4DBF-8C25-DF5C894A19A6"><gtr:id>47B97F2C-E1E7-4DBF-8C25-DF5C894A19A6</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Changalucha</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0901756"><gtr:id>2A423327-A935-47C6-88D6-8F2035C0C1FD</gtr:id><gtr:title>Development of Mwanza Intervention Trials Unit as a centre of excellence in HIV/STI prevention research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901756</gtr:grantReference><gtr:abstractText>Worldwide about 33 million adults and children are infected with the HIV virus that causes AIDS, and the number continues to grow each year. Sub-Saharan Africa continues to be the worst affected region, accounting for around two-thirds of all cases. Although there is no cure for HIV/AIDS, use of drugs called antiretrovirals can keep the infection under control and prevent it from developing into full-blown AIDS. A lot of progress has been made in the past five years in making such treatment available to more HIV-infected people in Africa who need it. However, there are still a lot of new HIV infections occurring each year, and this means that the number of people needing treatment will continue to increase. Unless we can find effective ways of preventing new infections, it is going to be very difficult and costly to provide lifelong treatment for an ever-increasing number of patients.

Only a few methods have been proven to be effective in preventing HIV infection and so we urgently need to find new methods. Several such methods are now in the pipeline and these will have to be tested carefully in well-designed trials to make sure they work. Scientists from the London School of Hygiene and Tropical Medicine have been doing research for many years with colleagues at the National Institute for Medical Research (NIMR) in Mwanza, Tanzania, to find effective ways of controlling HIV. In 2006, MRC provided initial funding to this group to set up a new trials unit in Mwanza, called the Mwanza Intervention Trials Unit. The aim of the unit is to develop as a centre of excellence in East Africa for trials of new methods to control HIV and other sexual health problems.

During the past three years, the unit has been set up and a building has been constructed to house it on the campus of NIMR in Mwanza. We have appointed a Scientific Director who is a respected Tanzanian scientist to lead the unit, and other senior staff have been recruited. We are now seeking funds to support the continued development of the unit. During the next few years we plan to carry out a range of trials looking at different methods of controlling HIV and other sexually transmitted infections. We will also be developing a comprehensive training programme so that the unit can help to develop capacity to conduct research in Africa.</gtr:abstractText><gtr:technicalSummary>The global HIV pandemic continues to grow and the number of new HIV infections each year greatly exceeds the number of HIV-infected patients starting antiretroviral treatment (ART). Unless effective HIV prevention efforts can reduce the incidence of new infections, it will become increasingly difficult to sustain treatment services for all who need them. New prevention methods of proven effectiveness are urgently needed but there is a dearth of clinical trial centres in Africa equipped to carry out trials of such interventions to the highest standards.

Recognising this need, the MRC made a special award to the London School of Hygiene and Tropical Medicine (LSHTM) in 2006 to support the establishment of the Mwanza Intervention Trials Unit (MITU) in Mwanza, Tanzania. This new trials facility was established as a joint initiative of LSHTM and the Tanzanian National Institute for Medical Research (NIMR), building on a long history of successful collaborative research between these two institutions on the prevention and control of HIV and other sexually transmitted infections (STIs). The MRC award funded the construction of purpose-built premises for the new unit and contributed to the initial core costs of the unit. Key senior staff of the unit have been appointed including a Scientific Director and Senior Research Administrator. The new unit was officially opened by the Tanzanian Minister of Health in July 2009.

The unit?s mission is to contribute to improving health through the development and evaluation of interventions against HIV and other health problems by conducting research, including clinical trials, to the highest international standards; to enhance the capacity to carry out such research in Tanzania and the East African region; and to contribute to the translation of research findings into health policy.

Although the unit aims to be self-sufficient with core costs supported through indirect cost recovery on research grants, some ongoing core support will be needed during the initial period of development. This application seeks funding for such support during the three years from the end of the initial award in April 2010. During this period, the unit will continue to conduct randomised trials of promising interventions against HIV and other STIs, including trials of vaginal microbicides, use of ART for HIV prevention, community-based behavioural interventions and human papillomavirus (HPV) vaccination. In addition, the unit will develop a comprehensive programme of capacity building including short courses, MSc and PhD training, staff mentoring and postdoctoral fellowships.</gtr:technicalSummary><gtr:fund><gtr:end>2014-10-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1090982</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Medical Research, Tanzania</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:department>Mwanza Intervention Trials Unit (MITU)</gtr:department><gtr:description>NIMR Mwanza Centre</gtr:description><gtr:id>AEB68D07-FC33-4CBC-8CAB-0962541730A7</gtr:id><gtr:impact>Strengthening research capacity in Africa; scientific publications; joint research grants</gtr:impact><gtr:partnerContribution>Providing laboratory and logistical infrastructure and support.</gtr:partnerContribution><gtr:piContribution>Technical (epidemiological, statistical, clinical, research) and administrative support.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Visited Harvard School of Public Health</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>132D85E6-8A54-47D4-B4C0-9A6FB28C4DB4</gtr:id><gtr:impact>This presentation was attended by 35 academic colleagues at Harvard

I presented research studies implemented by Mwanza Intervention Trials Unit and opportunities for possible collaboration in the future was discussed.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open day and exhibition</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>31205BAD-FFFA-4DDD-9D01-CA0065169636</gtr:id><gtr:impact>About 150 people attended the open day and were engaged

None</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with Tanzania Ministry of Health officials</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B234F0D5-185C-41FA-A85D-5C27F23319F3</gtr:id><gtr:impact>This meeting was attended by 40 policy makers. Preliminary results of MRC-funded chronic diseases project were presented and discussed.

This meeting helped to highlight the importance of chronic diseases in Tanzania</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dissemination of EDCTP Women's Health Project results to participants</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E1EEA407-2E9B-44E8-9397-AA8479814F0A</gtr:id><gtr:impact>We conducted 3 workshops (each attended by about 38 people) to provide results of this study to study participants and also health workers at 3 field sites in northern Tanzania.

These workshops helped participants to know the key findings from this research and raise awareness about factors associated with HIV in this part of Tanzania</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dissemination workshop (MDP 301 Trial)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5193AD05-2181-4C1D-BE3C-A75B9A5E2D26</gtr:id><gtr:impact>We had 45 people attending and who were very engaged during the workshop

No notable impact</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1395348</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>American Jewish World Service - Intervention with Microfinance for AIDS and Gender Equity (IMAGE) replication trial in Tanzania</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>American Jewish World Service (AJWS)</gtr:fundingOrg><gtr:id>A919E86C-9290-46C6-95DF-4F218930AA3F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9869</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK - HPV-021 Post Trial Vaccination</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>3FABC525-49F7-4086-9CB4-D3379F708677</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IPM - Microbiocides Development Programme(MDP) Phase III Clinical trial MDP301: Supplementary Funding for the Top-Up Substudy</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>International Partnership for Microbicides (IPM)</gtr:fundingOrg><gtr:id>538DAD60-BC4C-4A6E-8E97-4EFB76420C0A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>512624</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership (EDCTP)</gtr:department><gtr:description>EDCTP Strategic Primer Grant: Preparing for clinical trials of interventions to improve the reproductive health of adolescent girls in sub-Saharan Africa.</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>264453DB-966B-47BA-9B75-5B524B693594</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2303109</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC - Improving the health systems response to chronic diseases in Africa.</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>260ED7A9-9C9F-4B95-A7B0-A2EB829F8420</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9583</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UICC - HPV Pilot Demonstration Project</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>Union for International Cancer Control</gtr:fundingOrg><gtr:id>4C3CB784-A9F8-4920-AE8E-0F8DBD1E5971</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4020</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC - Operational study documenting existing health practices for the provision of Cotrimoxazole Preventive Therapy</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1C6C6E9E-9847-49C7-A593-12B16309A088</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Review results from trials of use of antiretroviral drugs for HIV prevention</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>F6987449-8EB5-49C9-8CF8-F255CCDF843F</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Workshop to review vaginal microbicide research findings and state of the field</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>91D097DB-81A9-444B-B744-63C73FF81D7B</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Scientific Technical Committee meeting attendance</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5B438752-BF09-4DE2-B2C4-67FA5878E2C0</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Consultations meeting for EDCTP in Lisbon, Portugal</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5AC28A5D-3127-49A4-BF2A-D4C389088C17</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>cervical cancer vaccination</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>48D7C797-B78F-4F22-83E3-2BE43FE3DE18</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have expanded our laboratory facilities by developing a new laboratory sample archive unit, biosafety level 3 laboratory, and development of capacity for isolation and preservation of peripheral blood mononuclear cells, and HIV viral genotyping</gtr:description><gtr:id>6EE67CEE-E00F-4008-AFCE-034ED23FAE4B</gtr:id><gtr:impact>Improved laboratory infrastructure have allowed to expansion of the range of research studies conducted at our centre</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Laboratory facility improvements</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>New lab techniques have been developed to study vaginal flora and how this influences the risk of HIV</gtr:description><gtr:id>331444B4-C71D-4B38-8576-3F7BC36BAEB7</gtr:id><gtr:impact>This have helped us to work in this new area of work to identify the role of vaginal microbiome in HIV transmission.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>New lab techniques introduced for studying vaginal microbiome</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have purchased android tablets which will be used in collecting data in a large clinical trial we are conducting in Tanzania</gtr:description><gtr:id>75E0ED27-9EDB-4567-9B9A-7A327FC7D7E5</gtr:id><gtr:impact>We expect this system will allow us to collect more accurate data and contribute in more timely data analysis</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Use of android tablets for data collection</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is an open source and GCP-compliant data management system which was introduced in all our studies in 2010</gtr:description><gtr:id>EFB61FD1-861D-4086-83B9-B7BFF6AB1D00</gtr:id><gtr:impact>This system have helped to standardise data management systems across our studies</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Introduced use of OpenClinica for data management</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We programmed PDAs to collect data in our large population survey</gtr:description><gtr:id>47764934-62CE-4498-A90F-6A345D2F48EE</gtr:id><gtr:impact>This helped our team to collect more accurate data and minimise time required to clean the data after the survey</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Use of electronic devices in collecting data</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39F0B00E-C003-42EE-A3D0-883300B78B78"><gtr:id>39F0B00E-C003-42EE-A3D0-883300B78B78</gtr:id><gtr:title>Preexposure prophylaxis for HIV infection among African women.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d4c56803a9aa7c182a1f1095533f87a7"><gtr:id>d4c56803a9aa7c182a1f1095533f87a7</gtr:id><gtr:otherNames>Van Damme L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF6D1DF0-A824-4B79-B83E-31158762270A"><gtr:id>EF6D1DF0-A824-4B79-B83E-31158762270A</gtr:id><gtr:title>HIV vaccines: current status worldwide and in Africa.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6af52587dac94a90b3811543d28aa3a1"><gtr:id>6af52587dac94a90b3811543d28aa3a1</gtr:id><gtr:otherNames>Fast PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/126993C5-7725-4268-974E-712521B2BFF1"><gtr:id>126993C5-7725-4268-974E-712521B2BFF1</gtr:id><gtr:title>Combination prevention: a deeper understanding of effective HIV prevention.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c84a60e43638612b008cc77a4f0cbbd"><gtr:id>8c84a60e43638612b008cc77a4f0cbbd</gtr:id><gtr:otherNames>Hankins CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44D53902-742C-4F7D-A520-7AB9E444FE27"><gtr:id>44D53902-742C-4F7D-A520-7AB9E444FE27</gtr:id><gtr:title>Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91e55291b93820fba1920c5866451af8"><gtr:id>91e55291b93820fba1920c5866451af8</gtr:id><gtr:otherNames>Quentin W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA5DEC1A-1CCB-430A-BED1-CB0A71214F8A"><gtr:id>FA5DEC1A-1CCB-430A-BED1-CB0A71214F8A</gtr:id><gtr:title>Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B7730829-9E24-40D5-B77D-5E594644C89C"><gtr:id>B7730829-9E24-40D5-B77D-5E594644C89C</gtr:id><gtr:title>Frequent intra-subtype recombination among HIV-1 circulating in Tanzania.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7a5b20bf342741546f2c2090ca3f2655"><gtr:id>7a5b20bf342741546f2c2090ca3f2655</gtr:id><gtr:otherNames>Kiwelu IE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F111D482-AF63-495C-8C61-68401E5B7621"><gtr:id>F111D482-AF63-495C-8C61-68401E5B7621</gtr:id><gtr:title>Epidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F8FE26C-0097-4F3B-B02D-6C93EB9D6DB0"><gtr:id>4F8FE26C-0097-4F3B-B02D-6C93EB9D6DB0</gtr:id><gtr:title>The long-term impact of the MEMA kwa Vijana adolescent sexual and reproductive health intervention: effect of dose and time since intervention exposure.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5336c45429e06079cfa27cb14bdf976"><gtr:id>b5336c45429e06079cfa27cb14bdf976</gtr:id><gtr:otherNames>Doyle AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3048F2E-270B-4145-A84A-9403833A781D"><gtr:id>D3048F2E-270B-4145-A84A-9403833A781D</gtr:id><gtr:title>Pregnancy and contraceptive use among women participating in the FEM-PrEP trial.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d2af347e66e4a245bd83c124fc43e31e"><gtr:id>d2af347e66e4a245bd83c124fc43e31e</gtr:id><gtr:otherNames>Callahan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/02A159FA-9E13-4862-ADC8-6EB8C4463079"><gtr:id>02A159FA-9E13-4862-ADC8-6EB8C4463079</gtr:id><gtr:title>Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9893893-5CD1-416C-B29D-52D4848EB79B"><gtr:id>A9893893-5CD1-416C-B29D-52D4848EB79B</gtr:id><gtr:title>Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2ee5a259427d1b43b39d37254afa9f13"><gtr:id>2ee5a259427d1b43b39d37254afa9f13</gtr:id><gtr:otherNames>Wigle J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5EDC99B4-ECC6-4AB4-82C9-CA04C9E2714D"><gtr:id>5EDC99B4-ECC6-4AB4-82C9-CA04C9E2714D</gtr:id><gtr:title>Public Health Aspects of HIV/AIDS in Low and Middle Income Countries</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/57b20e5db0ea88c7e764edac4ffa994f"><gtr:id>57b20e5db0ea88c7e764edac4ffa994f</gtr:id><gtr:otherNames>Weiss H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:isbn>978-0-387-72710-3</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4953DB97-52FB-44E5-915B-4D61275A6B35"><gtr:id>4953DB97-52FB-44E5-915B-4D61275A6B35</gtr:id><gtr:title>Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b09ed28b4debdf23975c32ced5a56234"><gtr:id>b09ed28b4debdf23975c32ced5a56234</gtr:id><gtr:otherNames>Watson-Jones D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B582CCAD-261E-439C-81D7-A9BF9A9415E9"><gtr:id>B582CCAD-261E-439C-81D7-A9BF9A9415E9</gtr:id><gtr:title>HIV Infection among Young People in Northwest Tanzania: The Role of Biological, Behavioural and Socio-Demographic Risk Factors.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dd331c2da067e91e7f6027aa2e1a3027"><gtr:id>dd331c2da067e91e7f6027aa2e1a3027</gtr:id><gtr:otherNames>Lemme F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/968C9118-A229-4A56-BB10-9FD7D7D9501F"><gtr:id>968C9118-A229-4A56-BB10-9FD7D7D9501F</gtr:id><gtr:title>HIV prevention research: taking stock and the way forward.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c148e9ffd758a895718cfd9de060388a"><gtr:id>c148e9ffd758a895718cfd9de060388a</gtr:id><gtr:otherNames>Hayes R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92DAF0E8-5176-46D3-B8AA-300FD7713120"><gtr:id>92DAF0E8-5176-46D3-B8AA-300FD7713120</gtr:id><gtr:title>Prevalence of human papillomavirus in adolescent girls before reported sexual debut.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/049ff5ffbd89e10d63f0d2ffbeecebb7"><gtr:id>049ff5ffbd89e10d63f0d2ffbeecebb7</gtr:id><gtr:otherNames>Houlihan CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4BFC4515-9D88-42CD-8156-5F4FE4299D8A"><gtr:id>4BFC4515-9D88-42CD-8156-5F4FE4299D8A</gtr:id><gtr:title>Vaginal practices diary: development of a pictorial data collection tool for sensitive behavioral data.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/77EFEFF7-D1C1-4883-8E8A-587F35A6542C"><gtr:id>77EFEFF7-D1C1-4883-8E8A-587F35A6542C</gtr:id><gtr:title>HIV prevention--where now? Background and introduction.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fc966e2f68bd54cbfd1ffa76bac0727f"><gtr:id>fc966e2f68bd54cbfd1ffa76bac0727f</gtr:id><gtr:otherNames>Kapiga S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/833C780F-257D-4BD6-B79D-76E1E1A761B3"><gtr:id>833C780F-257D-4BD6-B79D-76E1E1A761B3</gtr:id><gtr:title>FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/496586721802bbd8c3f6b35b851d8328"><gtr:id>496586721802bbd8c3f6b35b851d8328</gtr:id><gtr:otherNames>Corneli AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/044A84C6-42B7-485B-9A77-406E8888484C"><gtr:id>044A84C6-42B7-485B-9A77-406E8888484C</gtr:id><gtr:title>Behavioural interventions to reduce HIV risk: what works?</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b83685714df7a9da58afb85fe799bcd9"><gtr:id>b83685714df7a9da58afb85fe799bcd9</gtr:id><gtr:otherNames>Ross DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/586CB0F7-F4E4-46A4-A955-2F17DEAB289E"><gtr:id>586CB0F7-F4E4-46A4-A955-2F17DEAB289E</gtr:id><gtr:title>Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/306b2be0b9e5d27387f4d49625940343"><gtr:id>306b2be0b9e5d27387f4d49625940343</gtr:id><gtr:otherNames>Weber J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD2FEDA5-3121-4C13-A162-BA14E73CBA45"><gtr:id>DD2FEDA5-3121-4C13-A162-BA14E73CBA45</gtr:id><gtr:title>Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d78cc7da2f51e425b80850a1a629872f"><gtr:id>d78cc7da2f51e425b80850a1a629872f</gtr:id><gtr:otherNames>Peck R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AEA7FA95-C7D7-4738-B6BC-2F27264A89A1"><gtr:id>AEA7FA95-C7D7-4738-B6BC-2F27264A89A1</gtr:id><gtr:title>Intravaginal and menstrual practices among women working in food and recreational facilities in Mwanza, Tanzania: implications for microbicide trials.</gtr:title><gtr:parentPublicationTitle>AIDS and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c101700f19571c90b93dcd262ed68e1a"><gtr:id>c101700f19571c90b93dcd262ed68e1a</gtr:id><gtr:otherNames>Allen CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1090-7165</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EDB12BBA-8B5D-4EE9-8BBC-14547563B363"><gtr:id>EDB12BBA-8B5D-4EE9-8BBC-14547563B363</gtr:id><gtr:title>The Incidence of Human Papillomavirus in Tanzanian Adolescent Girls Before Reported Sexual Debut.</gtr:title><gtr:parentPublicationTitle>The Journal of adolescent health : official publication of the Society for Adolescent Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/049ff5ffbd89e10d63f0d2ffbeecebb7"><gtr:id>049ff5ffbd89e10d63f0d2ffbeecebb7</gtr:id><gtr:otherNames>Houlihan CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1054-139X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/168C9C61-7091-4392-A90B-AAAB0EA5FC6B"><gtr:id>168C9C61-7091-4392-A90B-AAAB0EA5FC6B</gtr:id><gtr:title>How long-distance truck drivers and villagers in rural southeastern Tanzania think about heterosexual anal sex: a qualitative study.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f8b294467e6720f251d0a9663b55737"><gtr:id>0f8b294467e6720f251d0a9663b55737</gtr:id><gtr:otherNames>Mtenga S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/454516CA-D3BD-4EC6-8843-140755F14EEE"><gtr:id>454516CA-D3BD-4EC6-8843-140755F14EEE</gtr:id><gtr:title>Risk factors for unplanned pregnancy among young women in Tanzania.</gtr:title><gtr:parentPublicationTitle>The journal of family planning and reproductive health care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0bbfc612092e7fbb6abd7b73f28bbdfb"><gtr:id>0bbfc612092e7fbb6abd7b73f28bbdfb</gtr:id><gtr:otherNames>Calvert C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-1893</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69D3CACF-5FD7-486A-B8CA-16F7F319A4ED"><gtr:id>69D3CACF-5FD7-486A-B8CA-16F7F319A4ED</gtr:id><gtr:title>Systematic review and meta-analysis: prevalence of alcohol use among young people in eastern Africa.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/059f2453051c8a7fc1ad033ab8b43e10"><gtr:id>059f2453051c8a7fc1ad033ab8b43e10</gtr:id><gtr:otherNames>Francis JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F73EF400-198A-4159-BD6A-EE3FC570F7E6"><gtr:id>F73EF400-198A-4159-BD6A-EE3FC570F7E6</gtr:id><gtr:title>Implementing good participatory practice guidelines in the FEM-PrEP Preexposure Prophylaxis Trial for HIV Prevention among African Women: a focus on local stakeholder involvement</gtr:title><gtr:parentPublicationTitle>Open Access Journal of Clinical Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/745cb56e2eb3c2698d60e25315c996a6"><gtr:id>745cb56e2eb3c2698d60e25315c996a6</gtr:id><gtr:otherNames>Mack N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F9EDBE4-6BC1-4CCD-9AA4-1DADFE8909B7"><gtr:id>5F9EDBE4-6BC1-4CCD-9AA4-1DADFE8909B7</gtr:id><gtr:title>Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dcaa55855fff49be1bc17f853b2f79e1"><gtr:id>dcaa55855fff49be1bc17f853b2f79e1</gtr:id><gtr:otherNames>Campbell MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3F355C3-22C1-4053-B9D8-AA80541D42EF"><gtr:id>A3F355C3-22C1-4053-B9D8-AA80541D42EF</gtr:id><gtr:title>Decreased renal function and associated factors in cities, towns and rural areas of Tanzania: a community-based population survey.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d78cc7da2f51e425b80850a1a629872f"><gtr:id>d78cc7da2f51e425b80850a1a629872f</gtr:id><gtr:otherNames>Peck R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AEE2E74E-146F-4C65-BD84-6370F9E20E04"><gtr:id>AEE2E74E-146F-4C65-BD84-6370F9E20E04</gtr:id><gtr:title>A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c9c9521f5f8e316f9b81a0d1bde5210a"><gtr:id>c9c9521f5f8e316f9b81a0d1bde5210a</gtr:id><gtr:otherNames>Remes P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4C4A107-E2F6-419C-8113-98BB9261DFF6"><gtr:id>C4C4A107-E2F6-419C-8113-98BB9261DFF6</gtr:id><gtr:title>Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d16a0e2cac032025257ed2f44c93f19d"><gtr:id>d16a0e2cac032025257ed2f44c93f19d</gtr:id><gtr:otherNames>Crook AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44BFED58-885B-4CDA-884F-12F644E19C76"><gtr:id>44BFED58-885B-4CDA-884F-12F644E19C76</gtr:id><gtr:title>Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d20bd7ee237ec2756247ebb9ee4c83bc"><gtr:id>d20bd7ee237ec2756247ebb9ee4c83bc</gtr:id><gtr:otherNames>Katz J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CDC44241-E46D-4162-A4AA-CDEB024EA662"><gtr:id>CDC44241-E46D-4162-A4AA-CDEB024EA662</gtr:id><gtr:title>Commentary: Non-communicable diseases in sub-Saharan Africa: a new global health priority and opportunity.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fc966e2f68bd54cbfd1ffa76bac0727f"><gtr:id>fc966e2f68bd54cbfd1ffa76bac0727f</gtr:id><gtr:otherNames>Kapiga S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6C578512-7582-499B-964F-596BA8FFE2DE"><gtr:id>6C578512-7582-499B-964F-596BA8FFE2DE</gtr:id><gtr:title>Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf363b2e8a7a081e0b3f34bbb55ec378"><gtr:id>cf363b2e8a7a081e0b3f34bbb55ec378</gtr:id><gtr:otherNames>Lingappa JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E60A7ADC-56D6-4C25-A419-6BC9552B6C7A"><gtr:id>E60A7ADC-56D6-4C25-A419-6BC9552B6C7A</gtr:id><gtr:title>HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7a5b20bf342741546f2c2090ca3f2655"><gtr:id>7a5b20bf342741546f2c2090ca3f2655</gtr:id><gtr:otherNames>Kiwelu IE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BC6CAE9F-CE10-417B-9A1D-B10FB533F3AD"><gtr:id>BC6CAE9F-CE10-417B-9A1D-B10FB533F3AD</gtr:id><gtr:title>A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f40f767256bf24f772526e320bc61de"><gtr:id>0f40f767256bf24f772526e320bc61de</gtr:id><gtr:otherNames>Pool R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B0A7328-D4BA-4D4F-95FD-05A2720BD678"><gtr:id>7B0A7328-D4BA-4D4F-95FD-05A2720BD678</gtr:id><gtr:title>Ethics, justice and community participation in the Microbicides Development Programme (MDP) Phase III trial in Mwanza, Tanzania.</gtr:title><gtr:parentPublicationTitle>The American journal of bioethics : AJOB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/95d37d831f7cc7077db21645b8ed08ed"><gtr:id>95d37d831f7cc7077db21645b8ed08ed</gtr:id><gtr:otherNames>Vallely A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1526-5161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD5A59CF-2082-43E9-8862-4EFFCDBF62F4"><gtr:id>DD5A59CF-2082-43E9-8862-4EFFCDBF62F4</gtr:id><gtr:title>No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17206a93cc42c912faf62768366872fb"><gtr:id>17206a93cc42c912faf62768366872fb</gtr:id><gtr:otherNames>LeGoff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/28A829BA-032B-4193-A08D-5E7A2BD5A874"><gtr:id>28A829BA-032B-4193-A08D-5E7A2BD5A874</gtr:id><gtr:title>Male circumcision for HIV prevention: current research and programmatic issues.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e71ad4d48ef9bef9e7d5fbe1bf10ff23"><gtr:id>e71ad4d48ef9bef9e7d5fbe1bf10ff23</gtr:id><gtr:otherNames>Weiss HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/669DF73E-7A32-48CE-806D-021060EA86EF"><gtr:id>669DF73E-7A32-48CE-806D-021060EA86EF</gtr:id><gtr:title>Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d99186fe36784093a89ae67dc4a70fcb"><gtr:id>d99186fe36784093a89ae67dc4a70fcb</gtr:id><gtr:otherNames>Brown J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/78945C56-C2E1-4595-87B1-F7BE00EA5CE0"><gtr:id>78945C56-C2E1-4595-87B1-F7BE00EA5CE0</gtr:id><gtr:title>Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/95d37d831f7cc7077db21645b8ed08ed"><gtr:id>95d37d831f7cc7077db21645b8ed08ed</gtr:id><gtr:otherNames>Vallely A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C0FA2BD-A31D-4159-9FD7-CCBAF40FDB88"><gtr:id>7C0FA2BD-A31D-4159-9FD7-CCBAF40FDB88</gtr:id><gtr:title>Bacterial Vaginosis and HIV: An Analysis of the MDP301 Trial</gtr:title><gtr:parentPublicationTitle>AIDS Research and Human Retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7c886ea6a1f8c575a3e82ba71366caa9"><gtr:id>7c886ea6a1f8c575a3e82ba71366caa9</gtr:id><gtr:otherNames>Joseph S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B33064B-780C-451E-83BF-1CCA56E927ED"><gtr:id>8B33064B-780C-451E-83BF-1CCA56E927ED</gtr:id><gtr:title>Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c148e9ffd758a895718cfd9de060388a"><gtr:id>c148e9ffd758a895718cfd9de060388a</gtr:id><gtr:otherNames>Hayes R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E36A637E-057C-41D6-8497-F30DC2CB8C6E"><gtr:id>E36A637E-057C-41D6-8497-F30DC2CB8C6E</gtr:id><gtr:title>Do behavioural differences help to explain variations in HIV prevalence in adolescents in sub-Saharan Africa?</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b98ae86d3ecb351864f1a74fe0245c95"><gtr:id>b98ae86d3ecb351864f1a74fe0245c95</gtr:id><gtr:otherNames>Chapman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E95C307-9210-4059-A334-C25E3707331D"><gtr:id>1E95C307-9210-4059-A334-C25E3707331D</gtr:id><gtr:title>Correlates of HIV-1 genital shedding in Tanzanian women.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/41cb267e09762c4a4206ce102aaca910"><gtr:id>41cb267e09762c4a4206ce102aaca910</gtr:id><gtr:otherNames>Tanton C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2911831-DC11-4A85-8272-9F39A1132A3C"><gtr:id>A2911831-DC11-4A85-8272-9F39A1132A3C</gtr:id><gtr:title>Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e44b068a4515b97d274cfe86774d6be"><gtr:id>1e44b068a4515b97d274cfe86774d6be</gtr:id><gtr:otherNames>Nel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E8147FD-8746-4C22-AF18-591EEA0DBFC2"><gtr:id>6E8147FD-8746-4C22-AF18-591EEA0DBFC2</gtr:id><gtr:title>Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f40f767256bf24f772526e320bc61de"><gtr:id>0f40f767256bf24f772526e320bc61de</gtr:id><gtr:otherNames>Pool R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E852E2C6-F898-4053-BFD5-E6C3E2558D8D"><gtr:id>E852E2C6-F898-4053-BFD5-E6C3E2558D8D</gtr:id><gtr:title>Prevalence of intimate partner violence and abuse and associated factors among women enrolled into a cluster randomised trial in northwestern Tanzania.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fc966e2f68bd54cbfd1ffa76bac0727f"><gtr:id>fc966e2f68bd54cbfd1ffa76bac0727f</gtr:id><gtr:otherNames>Kapiga S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/33A1F258-9A8C-406A-9CC6-F1B7A1CAAC96"><gtr:id>33A1F258-9A8C-406A-9CC6-F1B7A1CAAC96</gtr:id><gtr:title>High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1c77f630d3d3ad9bccec6f59fd83c3b9"><gtr:id>1c77f630d3d3ad9bccec6f59fd83c3b9</gtr:id><gtr:otherNames>Kavishe B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3B15DD62-9DAA-4BF1-BEBA-872A720839E0"><gtr:id>3B15DD62-9DAA-4BF1-BEBA-872A720839E0</gtr:id><gtr:title>Elevated blood pressure and correlates in a cohort of HIV-infected adults who started antiretroviral therapy when undernourished.</gtr:title><gtr:parentPublicationTitle>Journal of clinical hypertension (Greenwich, Conn.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4414e00a26ac7ad0cd4ec6c577128ab1"><gtr:id>4414e00a26ac7ad0cd4ec6c577128ab1</gtr:id><gtr:otherNames>PrayGod G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1524-6175</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0473F72C-9931-4933-A6F8-979E61919BD6"><gtr:id>0473F72C-9931-4933-A6F8-979E61919BD6</gtr:id><gtr:title>Risk factors of alcohol problem drinking among female bar/hotel workers in Moshi, Tanzania: a multi-level analysis.</gtr:title><gtr:parentPublicationTitle>AIDS and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ac7ad69d32a4e3d8215a58c536e5be2"><gtr:id>8ac7ad69d32a4e3d8215a58c536e5be2</gtr:id><gtr:otherNames>Ao TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-7165</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D020690F-C00D-403C-A318-6F3D66EB04FA"><gtr:id>D020690F-C00D-403C-A318-6F3D66EB04FA</gtr:id><gtr:title>Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b4b2b8b64f81791d0a1dafdd0538840"><gtr:id>8b4b2b8b64f81791d0a1dafdd0538840</gtr:id><gtr:otherNames>Mujugira A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3A5B191-B068-43C4-B0EF-885CCD4C0B01"><gtr:id>C3A5B191-B068-43C4-B0EF-885CCD4C0B01</gtr:id><gtr:title>Impact of the MEMA kwa Vijana adolescent sexual and reproductive health interventions on use of health services by young people in rural Mwanza, Tanzania: results of a cluster randomized trial.</gtr:title><gtr:parentPublicationTitle>The Journal of adolescent health : official publication of the Society for Adolescent Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb3f8440bbc73f59706bbfe116514c10"><gtr:id>eb3f8440bbc73f59706bbfe116514c10</gtr:id><gtr:otherNames>Larke N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1054-139X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70277868-76F3-49C8-A849-63117018BECE"><gtr:id>70277868-76F3-49C8-A849-63117018BECE</gtr:id><gtr:title>Baseline Characteristics of HIV-negative Women Enrolled into the Ring Study - A Clinical Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention</gtr:title><gtr:parentPublicationTitle>AIDS Research and Human Retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e44b068a4515b97d274cfe86774d6be"><gtr:id>1e44b068a4515b97d274cfe86774d6be</gtr:id><gtr:otherNames>Nel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A99B41E-B90B-4759-B068-841D1E5BA7FF"><gtr:id>8A99B41E-B90B-4759-B068-841D1E5BA7FF</gtr:id><gtr:title>The last decade of microbicide clinical trials in Africa: from hypothesis to facts.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2fb619ef0baba886f95886c59fc5ddf"><gtr:id>f2fb619ef0baba886f95886c59fc5ddf</gtr:id><gtr:otherNames>Ramjee G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA9F7B24-7535-40BE-B1C2-8786ECD2ADF1"><gtr:id>BA9F7B24-7535-40BE-B1C2-8786ECD2ADF1</gtr:id><gtr:title>Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7a92974f81628ba7317d86afc00bb978"><gtr:id>7a92974f81628ba7317d86afc00bb978</gtr:id><gtr:otherNames>Mackelprang RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C2B812E1-EA98-442F-BBF0-875DD63F4AF0"><gtr:id>C2B812E1-EA98-442F-BBF0-875DD63F4AF0</gtr:id><gtr:title>The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8cd5e2b4044d48718cb4deb2565d387b"><gtr:id>8cd5e2b4044d48718cb4deb2565d387b</gtr:id><gtr:otherNames>Kapiga SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F28696F7-A277-42C2-8BF3-93D12C872596"><gtr:id>F28696F7-A277-42C2-8BF3-93D12C872596</gtr:id><gtr:title>Vaginal practices among women at high risk of HIV infection in Uganda and Tanzania: recorded behaviour from a daily pictorial diary.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D41F2C7D-EC80-4F50-914C-1C192EC9CA2D"><gtr:id>D41F2C7D-EC80-4F50-914C-1C192EC9CA2D</gtr:id><gtr:title>Association of schistosomiasis with false-positive HIV test results in an African adolescent population.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/956b282636f8fe08438e0143dba8bf95"><gtr:id>956b282636f8fe08438e0143dba8bf95</gtr:id><gtr:otherNames>Everett DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/81449D39-6B63-436B-9B7B-3898D21E4637"><gtr:id>81449D39-6B63-436B-9B7B-3898D21E4637</gtr:id><gtr:title>Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting.</gtr:title><gtr:parentPublicationTitle>AIDS and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6b78663db318ad79a3cf319b9bc1788c"><gtr:id>6b78663db318ad79a3cf319b9bc1788c</gtr:id><gtr:otherNames>Baisley K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1090-7165</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901756</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>6A8830E7-54E9-46E8-8AF8-96B20A4D9DDC</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.5  Resources and infrastructure (prevention)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>